Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Gonadal and Placental Hormones

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...

Regression Toward the Mean

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hematological Evaluation and Management of Menorrhagia in Adolescents: Lessons from Adolescent Heavy Menstrual Bleeding Clinics.

Acta haematologica·2025

Same author

The Association between Advanced Maternal Age and the Manifestations of Preeclampsia with Severe Features.

Journal of clinical medicine·2023

Same author

[TREATMENT OF SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS (SSRIS AND SNRIS) DURING PREGNANCY AND LACTATION].

Harefuah·2023

Same author

Maternal and Newborn Thyroid Hormone, and the Association With Polychlorinated Biphenyls (PCBs) Burden: The EHF (Environmental Health Fund) Birth Cohort.

Frontiers in pediatrics·2021

Same author

Effect of domperidone on insufficient lactation in puerperal women: a systematic review and meta-analysis of randomized controlled trials.

Obstetrics and gynecology international·2012

Same author

Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature.

The Journal of rheumatology·2011

Search research articles

Related Experiment Video

Updated: Jun 7, 2026

Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization

Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization

Published on: June 17, 2025

Toward improved pregnancy labelling.

Gideon Koren¹, Sachi Sakaguchi, Chagit Klieger

¹Motherisk Program, University of Toronto, Canada.

Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique

|November 3, 2010

Summary

This summary is machine-generated.

The FDA

More Related Videos

Pregnancy and Nursing Management for Embryo-Transferred and Genetically Modified Rabbits

Pregnancy and Nursing Management for Embryo-Transferred and Genetically Modified Rabbits

Published on: December 13, 2024

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Related Experiment Videos

Last Updated: Jun 7, 2026

Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization

Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization

Published on: June 17, 2025

Pregnancy and Nursing Management for Embryo-Transferred and Genetically Modified Rabbits

Pregnancy and Nursing Management for Embryo-Transferred and Genetically Modified Rabbits

Published on: December 13, 2024

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Area of Science:

Pharmacology
Obstetrics
Drug Safety

Background:

Drug labeling for pregnancy is crucial for clinical decision-making.
Existing pregnancy drug labeling systems have limitations.
The FDA is replacing the outdated A,B,C,D,X system with new guidelines.

Purpose of the Study:

To evaluate the new FDA drug labeling guidelines for pregnancy and breastfeeding.
To illustrate the application of the new system across diverse clinical scenarios in pregnancy.

Main Methods:

Analysis of three medications used in distinct pregnancy situations: acute infection, chronic pain, and labor.
Documentation of the practical implementation of the new FDA labeling system.

Main Results:

The new FDA guidelines offer a more nuanced approach to drug information in pregnancy.
The system addresses different clinical contexts, including acute infections, chronic pain, and labor.
Advantages and challenges associated with the new labeling system were identified.

Conclusions:

The new FDA pregnancy drug labeling system aims to improve prescribing information.
The system's practical application highlights both benefits and areas for refinement.
Continued evaluation is necessary to optimize drug safety during pregnancy and breastfeeding.